Skip to content
Skip to navigation menu
Cardiff-developed drug completes phase 2 human trial
Professor Chris McGuigan’s anti-viral discovery set for final trials
Drug discovery in line to be University first
A company working in partnership with the University to develop a new drug for shingles has been recognised at the Cardiff University Innovation Awards.
Funding for further work on promising compounds
US deal enables first clinical trials
This is an externally hosted beta service offered by Google.